Cargando…
Covalent inhibition of NSD1 histone methyltransferase
The NSD family of histone methyltransferases is associated with various malignancies, including aggressive acute leukemia with NUP98-NSD1 translocation. While NSD proteins represent attractive drug targets, their catalytic SET domains exist in autoinhibited conformation, presenting significant chall...
Autores principales: | Huang, Huang, Howard, Christina A., Zari, Sergei, Cho, Hyo Je, Shukla, Shirish, Li, Hao, Ndoj, Juliano, González-Alonso, Paula, Nikolaidis, Caroline, Abbott, Joshua, Rogawski, David S., Potopnyk, Mykhaylo A., Kempinska, Katarzyna, Miao, Hongzhi, Purohit, Trupta, Henderson, Andrew, Mapp, Anna, Sulis, Maria Luisa, Ferrando, Adolfo, Grembecka, Jolanta, Cierpicki, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669657/ https://www.ncbi.nlm.nih.gov/pubmed/32868895 http://dx.doi.org/10.1038/s41589-020-0626-6 |
Ejemplares similares
-
Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
por: Rogawski, David S., et al.
Publicado: (2021) -
Theoretical models of inhibitory activity for inhibitors of protein–protein interactions: targeting menin–mixed lineage leukemia with small molecules
por: Jedwabny, Wiktoria, et al.
Publicado: (2017) -
Rational Design
of Orthogonal Multipolar Interactions
with Fluorine in Protein–Ligand Complexes
por: Pollock, Jonathan, et al.
Publicado: (2015) -
Small molecule inhibitors targeting Polycomb Repressive Complex 1 RING domain
por: Shukla, Shirish, et al.
Publicado: (2021) -
The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)